Avanos Medical Q1 revenue rises 8.8% on nutrition segment growth

Avanos Medical

05/05/2026 12:15

Overview

U.S. medical technology firm's Q1 revenue rose 8.8% yr/yr, led by Specialty Nutrition Systems

Adjusted diluted EPS for Q1 fell to $0.22 from $0.26 a year ago

Company in process of being acquired by American Industrial Partners for $1.27 bln

Outlook

Company did not provide specific guidance for the current quarter or full year

Result Drivers

SPECIALTY NUTRITION SYSTEMS GROWTH - Double-digit organic revenue growth in SNS segment, led by neonate solutions and enteral feeding

PAIN MANAGEMENT & RECOVERY FLAT - PM&R segment sales were flat as growth in radiofrequency ablation was offset by a decline in surgical pain and recovery

Company press release: ID:nPn644SVra

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
$182.20 mln
$170 mln (1 Analyst)
Q1 Net Income
$5.10 mln
Q1 EBITDA
$19.10 mln
Q1 Gross Profit
$94.20 mln
Q1 Operating Income
$8.90 mln
Q1 Pretax Profit
$7.60 mln


Analyst Coverage

The one available analyst rating on the shares is "hold"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

The stock recently traded at 23 times the next 12-month earnings vs. a P/E of 14 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)